Al-Dawaa Medical Services Valuation
Is 4163 undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
4/6Valuation Score 4/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of 4163 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: 4163 (SAR96) is trading below our estimate of fair value (SAR120.33)
Significantly Below Fair Value: 4163 is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for 4163?
Other financial metrics that can be useful for relative valuation.
What is 4163's n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | ر.س8.16b |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 1.7x |
Enterprise Value/EBITDA | 15.6x |
PEG Ratio | 1.6x |
Price to Earnings Ratio vs Peers
How does 4163's PE Ratio compare to its peers?
Company | Forward PE | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 24.6x | ||
4164 Nahdi Medical | 19.9x | 8.0% | ر.س17.2b |
4161 BinDawood Holding | 28.6x | 10.1% | ر.س8.2b |
4162 Almunajem Foods | 22.8x | n/a | ر.س7.4b |
4001 Abdullah Al-Othaim Markets | 27.2x | 11.8% | ر.س10.7b |
4163 Al-Dawaa Medical Services | 23x | 14.1% | ر.س8.1b |
Price-To-Earnings vs Peers: 4163 is good value based on its Price-To-Earnings Ratio (23x) compared to the peer average (24.6x).
Price to Earnings Ratio vs Industry
How does 4163's PE Ratio compare vs other companies in the Asian Consumer Retailing Industry?
Price-To-Earnings vs Industry: 4163 is expensive based on its Price-To-Earnings Ratio (23x) compared to the Asian Consumer Retailing industry average (16.4x).
Price to Earnings Ratio vs Fair Ratio
What is 4163's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PE Ratio | 23.1x |
Fair PE Ratio | 24.6x |
Price-To-Earnings vs Fair Ratio: 4163 is good value based on its Price-To-Earnings Ratio (23x) compared to the estimated Fair Price-To-Earnings Ratio (24.6x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
---|---|---|---|---|---|---|---|
Current | ر.س96.50 | ر.س110.32 +14.3% | 8.2% | ر.س125.00 | ر.س99.71 | n/a | 6 |
Sep ’25 | ر.س92.40 | ر.س110.49 +19.6% | 8.4% | ر.س126.00 | ر.س99.71 | n/a | 6 |
Aug ’25 | ر.س87.90 | ر.س113.34 +28.9% | 9.5% | ر.س130.00 | ر.س99.71 | n/a | 6 |
Jul ’25 | ر.س88.00 | ر.س113.34 +28.8% | 9.5% | ر.س130.00 | ر.س99.71 | n/a | 6 |
Jun ’25 | ر.س89.90 | ر.س114.17 +27.0% | 8.6% | ر.س130.00 | ر.س99.71 | n/a | 6 |
May ’25 | ر.س95.80 | ر.س116.26 +21.4% | 8.1% | ر.س130.00 | ر.س101.00 | n/a | 5 |
Apr ’25 | ر.س94.80 | ر.س118.46 +25.0% | 6.3% | ر.س130.00 | ر.س107.00 | n/a | 5 |
Mar ’25 | ر.س114.40 | ر.س118.46 +3.5% | 6.3% | ر.س130.00 | ر.س107.00 | n/a | 5 |
Feb ’25 | ر.س112.20 | ر.س118.46 +5.6% | 6.3% | ر.س130.00 | ر.س107.00 | n/a | 5 |
Jan ’25 | ر.س106.00 | ر.س115.46 +8.9% | 4.2% | ر.س120.30 | ر.س107.00 | n/a | 5 |
Dec ’24 | ر.س102.20 | ر.س109.46 +7.1% | 5.0% | ر.س115.00 | ر.س100.30 | n/a | 5 |
Nov ’24 | ر.س94.90 | ر.س106.06 +11.8% | 5.4% | ر.س115.00 | ر.س100.00 | n/a | 5 |
Oct ’24 | ر.س97.90 | ر.س106.06 +8.3% | 5.4% | ر.س115.00 | ر.س100.00 | n/a | 5 |
Sep ’24 | ر.س95.60 | ر.س105.06 +9.9% | 5.2% | ر.س115.00 | ر.س100.00 | ر.س92.40 | 5 |
Aug ’24 | ر.س101.40 | ر.س103.46 +2.0% | 7.2% | ر.س115.00 | ر.س92.00 | ر.س87.90 | 5 |
Jul ’24 | n/a | ر.س99.06 0% | 15.4% | ر.س115.00 | ر.س70.00 | ر.س88.00 | 5 |
Jun ’24 | ر.س90.00 | ر.س93.33 +3.7% | 17.7% | ر.س105.00 | ر.س70.00 | ر.س89.90 | 3 |
May ’24 | ر.س77.80 | ر.س62.00 -20.3% | 12.9% | ر.س70.00 | ر.س54.00 | ر.س95.80 | 2 |
Dec ’23 | ر.س72.50 | ر.س67.00 -7.6% | 25.4% | ر.س84.00 | ر.س50.00 | ر.س102.20 | 2 |
Oct ’23 | ر.س79.70 | ر.س86.00 +7.9% | 2.3% | ر.س88.00 | ر.س84.00 | ر.س97.90 | 2 |
Sep ’23 | ر.س76.70 | ر.س86.00 +12.1% | 2.3% | ر.س88.00 | ر.س84.00 | ر.س95.60 | 2 |
Analyst Forecast: Target price is less than 20% higher than the current share price.